Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weibin Liu

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
International Immunopharmacology|January 13, 2023
JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathwayYaru Lu, Qian Ma, Lu Yu, et al.
Biochemical and Biophysical Research Communications|December 12, 2018
The practical self-targeted oncolytic adenoviral nanosphere based on immuno-obstruction method via polyprotein surface precipitation technique enhances transfection efficiency for virotherapyHao Ran, Guilan Quan, Ying Huang, et al.
Frontiers in Neurology|September 27, 2022
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patientsXin Huang, Hao Ran, Yingkai Li, et al.
The International Journal of Neuroscience|August 15, 2017
Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patientsYan Li, Haiyan Wang, Pei Chen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 15, 2017
Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysisKai Zhu, Jiaoxing Li, Xin Huang, et al.
Computers in Biology and Medicine|April 19, 2024
DesTrans: A medical image fusion method based on Transformer and improved DenseNetYumeng Song, Yin Dai, Weibin Liu, et al.
Annals of Surgical Oncology|September 7, 2025
Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung CancerWeijin Xiao, Jianqing Zheng, Yujie Deng, et al.
Frontiers in Physiology|March 25, 2024
<i>BmC/EBPZ</i> gene is essential for the larval growth and development of silkworm, <i>Bombyx mori</i>Xinglin Mei, Tianchen Huang, Anli Chen, et al.
Neuromuscular Disorders : NMD|May 11, 2020
AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature reviewYaru Lu, Hao Ran, Wenhao Yang, et al.
Journal of Neuroimmunology|February 9, 2025
Corrigendum to "Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia gravis patients" [Journal of Neuroimmunology. 2024 Nov 15:396:578464]Yingkai Li, Pei Chen, Xin Huang, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
International Immunopharmacology|January 13, 2023
JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathwayYaru Lu, Qian Ma, Lu Yu, et al.
Biochemical and Biophysical Research Communications|December 12, 2018
The practical self-targeted oncolytic adenoviral nanosphere based on immuno-obstruction method via polyprotein surface precipitation technique enhances transfection efficiency for virotherapyHao Ran, Guilan Quan, Ying Huang, et al.
Frontiers in Neurology|September 27, 2022
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patientsXin Huang, Hao Ran, Yingkai Li, et al.
The International Journal of Neuroscience|August 15, 2017
Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patientsYan Li, Haiyan Wang, Pei Chen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 15, 2017
Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysisKai Zhu, Jiaoxing Li, Xin Huang, et al.
Computers in Biology and Medicine|April 19, 2024
DesTrans: A medical image fusion method based on Transformer and improved DenseNetYumeng Song, Yin Dai, Weibin Liu, et al.
Annals of Surgical Oncology|September 7, 2025
Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung CancerWeijin Xiao, Jianqing Zheng, Yujie Deng, et al.
Frontiers in Physiology|March 25, 2024
<i>BmC/EBPZ</i> gene is essential for the larval growth and development of silkworm, <i>Bombyx mori</i>Xinglin Mei, Tianchen Huang, Anli Chen, et al.
Neuromuscular Disorders : NMD|May 11, 2020
AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature reviewYaru Lu, Hao Ran, Wenhao Yang, et al.
Journal of Neuroimmunology|February 9, 2025
Corrigendum to "Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia gravis patients" [Journal of Neuroimmunology. 2024 Nov 15:396:578464]Yingkai Li, Pei Chen, Xin Huang, et al.
Pageof 9